Erratum: Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial

Yiwen Ling

1Arthur D. Riggs Diabetes and Metabolism Research Institute, The Beckman Research Institute of City of Hope, Duarte, United States

Li Xuan

Na Xu

Jiangsu Collaborative Innovation Center of Biomedical Functional Materials, Nanjing Drum Tower Hospital, College of Chemistry and Materials Science

Fen Huang

Zhiping Fan

1Nanfang Hospital, Southern Medical University, Guangzhou, China

Ziwen Guo

Xiaojun Xu

Department of Pharmacy, Center for Membrane Receptor and Brain Medicine, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine

Hui Liu

Ren Lin

1Nanfang Hospital, Southern Medical University, Guangzhou, China

Sijian Yu

1Nanfang hospital, Guangzhou, China

Haiyan Zhang

State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica

Hua Jin

Meiqing Wu

Can Liu

Xinquan Liang

Jining Medical University, Jining, Shandong, China

Ruiming Ou

Yuping Zhang

Xiaodan Liu

Hong Qu

6Department of Hematology, The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou, China

Xiao Zhai

Jing Sun

Ying Zhao

Division of Biobased Chemicals

Qifa Liu

1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China